Steven P. Gelone - 06 Oct 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRVF)

Role
President and COO, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Issuer symbol
NBRVF
Transactions as of
06 Oct 2021
Transactions value $
-$99
Form type
4
Date filed
08 Oct 2021, 16:41
Previous filing
04 Oct 2021
Next filing
01 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRVF Ordinary Shares Tax liability -$99 -92 -0.03% $1.08 367K 06 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.